Nigeria’s healthcare system could be entering a period where distance matters less in the diagnosis of serious diseases. The combination of artificial intelligence (AI), digital pathology and telepathology has the potential to connect patients in underserved communities with specialist expertise that is often concentrated in major cities.
For a country as large and populous as Nigeria, this could become particularly important. A patient in a rural community should not have to travel hundreds of kilometres simply because the specialist capable of interpreting a tissue sample is based in Lagos, Abuja, Ibadan or another major urban centre.
Telepathology provides a practical way of addressing part of this problem. Instead of physically transporting glass slides to another location, pathology samples can be digitised and transmitted electronically for review by specialists elsewhere. This can make collaboration faster while creating opportunities for experts to support hospitals that do not have sufficient pathology personnel.
AI could add another layer to this system. Once pathology slides are converted into high-resolution digital images, AI systems can assist specialists by identifying patterns, highlighting suspicious areas and supporting the analysis of certain diseases. Research into computational pathology suggests that AI is likely to become increasingly integrated into pathology workflows during the coming years, although questions around accuracy, regulation and clinical responsibility remain.
The important point is that AI should not be viewed simply as a replacement for Nigerian doctors. Its greater value may be in helping existing specialists work more efficiently and extending their expertise to more patients.
Also Read: Tinubu’s Health Tech Drive Could Produce Africa’s Next Billion-Dollar Startups
Back Story: Why Telepathology Matters in Nigeria
The need for better access to pathology services is not new. A 2022 study examining telepathology in Nigeria highlighted the shortage of pathology personnel and the high cost of maintaining pathology facilities as major barriers to timely and quality diagnosis. The researchers also noted that Nigeria had roughly 105 pathologists for a population estimated at about 200 million at the time.
That imbalance has serious implications. Pathology is central to diagnosing many diseases, particularly cancers, because doctors often need laboratory examination of tissue samples before determining the most appropriate treatment.
Telepathology could help bridge the geographical gap. A local hospital could collect and prepare a sample while a specialist elsewhere reviews the digitised image. Beyond diagnosis, such a system could support second opinions, training, quality assurance and collaboration between Nigerian institutions and specialists abroad.
Recent developments in digital pathology globally show why this model is becoming more realistic. Modern telepathology systems are increasingly designed to reduce geographical barriers, improve access to expertise and potentially shorten diagnostic turnaround times.
What AI Could Bring to Nigerian Healthcare
The most immediate opportunity may be improved efficiency.
Pathologists routinely examine large numbers of images and search for subtle cellular patterns. AI can assist with repetitive image-analysis tasks, potentially helping specialists identify areas that deserve closer attention. It can also support quantitative analysis that may be difficult or time-consuming to perform manually.
For Nigerian hospitals, the combination of AI and telepathology could therefore create a network in which scarce expertise is shared more effectively. Instead of every hospital needing a large team of highly specialised pathologists, regional facilities could connect to a wider pool of experts.
This could be especially valuable for cancer diagnosis. Digital images can be stored, reviewed and shared, allowing specialists to compare cases and provide second opinions without requiring physical transportation of slides.
AI research in pathology is already moving beyond theoretical possibilities. Studies have found that artificial intelligence can assist with specific diagnostic and analytical tasks, although performance can vary depending on the disease, dataset and clinical environment. Researchers have consequently stressed the importance of clinical validation before widespread adoption.
For Nigeria, this means technology should complement medical expertise rather than replace it.
Also Read: African Students Are Becoming AI Builders, Not Just AI Users
The Challenges Nigeria Must Solve
The promise is significant, but implementation will not be automatic. Digital pathology requires scanners, reliable electricity, internet connectivity, secure data systems and trained personnel. These are not small challenges in a healthcare system where many facilities still struggle with basic infrastructure.
Cost is another consideration. Telepathology can require substantial investment at the beginning, even though its long-term benefits may outweigh those costs.
There are also questions about patient privacy, cybersecurity, regulation and responsibility when an AI-supported diagnosis is wrong. Nigerian healthcare institutions will need clear standards governing how patient data is stored, transferred and processed, as well as rules defining the role of AI in clinical decisions.
Most importantly, Nigeria should avoid treating technology as a shortcut around deeper healthcare problems. AI cannot compensate for poorly equipped laboratories, unreliable electricity or a shortage of trained medical professionals.
The opportunity over the next decade is therefore not simply to introduce AI into hospitals. It is to build a connected diagnostic ecosystem where Nigerian pathologists can collaborate across states, institutions and borders.
If the right infrastructure, regulation and training are put in place, telepathology could bring specialist knowledge closer to patients while AI helps doctors handle growing diagnostic demands. For Nigeria, that could mean faster access to expertise, stronger collaboration and potentially better outcomes for patients who have historically been disadvantaged by geography.
